Related Experiment Video
Updated: Jan 14, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Microbiome as a Potential Target for Treatment and Prevention of Atopic Dermatitis
1Department of Dermatology, University of California, San Diego, La Jolla, CA 92122, USA.
None:
The skin microbiome in patients with atopic dermatitis (AD) is dysregulated with disproportionate dominance of Staphylococcus aureus, decreased microbial diversity, and decline in populations of commensal organisms with beneficial antimicrobial properties, such as coagulase-negative Staphylococci (CoNS). Emerging therapeutics target dysbiosis, S aureus elimination, CoNS growth, and microbial diversity improvement in the treatment and prevention of AD.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

